All Products
  • Antibodies
  • Kits
  • Peptides
  • Proteins
  • Biochemicals
CH
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
Biosimilar Antibodies
Path：Home > Products > Antibodies > Biosimilar Antibodies
Products
Products
Research Grade Luspatercept
All
  • Catalog： TD-HF869016
  • Clonality：
  • Application： Research Grade Biosimilar
  • Synonyms： ACE-536,luspatercept–aamt,CAS:1373715-00-4
  • Specification：
    1mg
  • Prices：
    ¥询价
Customized service consulting
Information
FAQ
Experimental program
Related Products
Bibliography

Research Grade Luspatercept

Catalog No. TD-HF869016
Species reactivity Human
Applications Research Grade Biosimilar
Isotype Fusion - [ACVR2B (activin A receptor type 2B, ActR-IIB, ActRIIB)]2 - IGHG1 Fc (Fragment constant)
Expression system Mammalian Cells
Target GDF11, BMP-11, BMP11, Growth/differentiation factor 11, GDF-11, Bone morphogenetic protein 11
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession O95390
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names ACE-536,luspatercept–aamt,CAS:1373715-00-4
Background Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia.
Note For research use only. Not for use in clinical or therapeutic applications.